Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement next post S&P 500 Rises from Bearish to Neutral, But Will It Last? You may also like Providence Extends Private Placement March 29, 2025 Strategic Partnership secures long-term future for the Storm... April 9, 2025 Finlay Minerals Enters into Earn-In Agreements with Freeport... April 18, 2025 Finlay Minerals Enters into Earn-In Agreements with Freeport... April 19, 2025 Trump’s Auto Tariffs Ignite Global Trade Tensions and... March 28, 2025 $4,000 Gold on the Horizon? Why Smart Money... April 26, 2025 Altech – CERENERGY Cells Test Safe Under Extreme... April 3, 2025 Finlay Minerals Enters into Earn-In Agreements with Freeport... April 20, 2025 Silver Tiger Metals Inc. Announces Bought Deal Financing March 26, 2025 Oil Markets Buckle Under Tariff Pressure, Recession Fears... April 9, 2025